<DOC>
	<DOC>NCT02926300</DOC>
	<brief_summary>The purpose of this clinical trial is to evaluate long-term safety and efficacy in patients who has history of FURESTEM-CD injection at least once.</brief_summary>
	<brief_title>Long-term Safety and Efficacy of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease(CD)</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>patients who has history of FURESTEMCD Inj. injection at least once. patients who understand and voluntarily sign an informed consent form. any other condition which the PI judges would make subject unsuitable for study participation.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>crohn's disease</keyword>
	<keyword>stem cell therapy</keyword>
	<keyword>inflammatory bowel disease</keyword>
	<keyword>hUCB-MSC</keyword>
	<keyword>UCB-MSC</keyword>
	<keyword>Umbilical cord Blood</keyword>
</DOC>